AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Etoposide in South Africa

13 products registered with SAHPRA 8 active

Brand / ProductReg. No.HolderStatusExpires
ETOPOSIDE - HEXAL 100 mg/5 ml37/34/0170Sandoz South Africa (Pty) Ltdsuspended18 Aug 2025
ETOPOSIDE - HEXAL 50 mg/2,5 ml37/34/0169Sandoz South Africa (Pty) Ltdsuspended18 Aug 2025
P & U ETOPOSIDE CSV 100 mg / 5 ml INJECTION30/26/0410Pfizer Laboratories (Pty) Ltdsuspended14 Feb 2023
ETOPOSIDE-HEXAL 200 mg/10ml37/34/0171Sandoz South Africa (Pty) Ltdsuspended20 Jan 2022
ETOPOSIDE-HEXAL 400 mg/20ml37/34/0172Sandoz South Africa (Pty) Ltdsuspended20 Jan 2022
KEMOSID 100A38/26/0387Cipla Medpro (Pty) Ltdactive1 Jan 1900
HX - ETOPOSIDE 400 mg/20 ml37/34/0177Oethmaan Biosims (Pty) Ltdactive1 Jan 1900
HX - ETOPOSIDE 1 000 mg/50 ml37/34/0178Oethmaan Biosims (Pty) Ltdactive1 Jan 1900
ETOPOSIDE 100 mg/5 ml ADCO42/26/0017Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900
EPOSIN32/26/0263Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
HX - ETOPOSIDE 50 mg/2,5 ml37/34/0174Oethmaan Biosims (Pty) Ltdactive1 Jan 1900
HX - ETOPOSIDE 100 mg/5 ML37/34/0175Oethmaan Biosims (Pty) Ltdactive1 Jan 1900
HX - ETOPOSIDE 200 mg/10 ML37/34/0176Oethmaan Biosims (Pty) Ltdactive1 Jan 1900

EtoposideSAHPRA Registration Details

SAHPRA (South Africa) has 13 registered products containing Etoposide, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Etoposide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.